Previous studies established that attenuating Wnt/b-catenin signaling limits lung fibrosis in the bleomycin mouse model of this disease, but the contribution of this pathway to distinct lung cell phenotypes relevant to tissue repair and fibrosis remains incompletely understood. Using microarray analysis, we found that bleomycin-injured lungs from mice that lack the Wnt coreceptor low density lipoprotein receptor-related protein 5 (Lrp5) and exhibit reduced fibrosis showed enrichment for pathways related to extracellular matrix processing, immunity, and lymphocyte proliferation, suggesting the contribution of an immunematrix remodeling axis relevant to fibrosis. Activation of b-catenin signaling was seen in lung macrophages using the b-catenin reporter mouse, Axin2
. Analysis of lung immune cells by flow cytometry after bleomycin administration revealed that Lrp5 2/2 lungs contained significantly fewer Siglec F low alveolar macrophages, a cell type previously implicated as positive effectors of fibrosis. Macrophagespecific deletion of b-catenin in CD11c cre ;b-catenin flox mice did not prevent development of bleomycin-induced fibrosis but facilitated its resolution by 8 weeks. In a nonresolving model of fibrosis, intratracheal administration of asbestos in Lrp5 2/2 mice also did not prevent the development of fibrosis but hindered the progression of fibrosis in asbestos-treated Lrp5 2/2 lungs, phenocopying the findings in bleomycin-treated CD11c cre ;b-catenin flox mice. Activation of b-catenin signaling using lithium chloride resulted in worsened fibrosis in wild-type mice, further supporting that the effects of loss of Lrp5 are directly mediated by Wnt/b-catenin signaling. Together, these data suggest that lung myeloid cells are responsive to Lrp5/b-catenin signaling, leading to differentiation of an alveolar macrophage subtype that antagonizes the resolution of lung fibrosis.
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Clinical Relevance
The findings from this research demonstrate, for the first time, that a developmental pathway alters lung repair after injury by impacting macrophage differentiation. This evidence adds to the growing body of literature supporting the importance of monocytes-macrophages to lung fibrosis and resolution. Potential future interventions for pulmonary fibrosis may be directed toward strategies that modulate the Wnt/b-catenin pathway in monocyte-macrophage cells.
Macrophages are important contributors not only to innate immunity, but also to the normal development and repair of tissues (1) . Current evidence suggests that immune cells of the monocyte-macrophage lineage are recruited during tissue injury and contribute dynamic functions that promote either the persistence or resolution of fibrosis. Recruited monocytes can promote the resolution of fibrotic disease by several potential mechanisms, including differentiating into regulatory macrophages, inhibiting T lymphocyte and fibroblast proliferation, degrading interstitial collagen via matrix metalloproteinases (MMPs), phagocytosing extracellular matrix and cellular debris, and promoting myofibroblast apoptosis (2) . The importance and diversity of macrophage functions in tissue development and homeostasis is highlighted by studies in which mice lacking distinct macrophage subpopulations revealed surprising developmental abnormalities, such as disrupted bone morphogenesis (3) , and in which macrophages expressing Wnt ligands promoted activation of nearby hepatocyte progenitors in regenerating livers (4) .
In idiopathic pulmonary fibrosis, developmental pathways, such as Wnt/bcatenin, have been implicated in the cycle of aberrant wound repair, resulting in persistent fibrosis (5) . The Wnt/b-catenin pathway is best known for determining cell fate decisions during tissue development (6) (7) (8) and in homeostasis (9) (10) (11) (12) (13) (14) (15) . Although lung epithelial-and fibroblast-specific roles of Wnt signaling relevant to fibrosis have been described (16, 17) , less is understood about how Wnt signaling affects the immune system of the lung. Recent reports suggest that Wnt/b-catenin signaling may have opposing effects in different immune cell types (18) (19) (20) (21) . In a mouse model of inflammatory bowel disease, activation of b-catenin signaling in CD11c 1 CD11b
1/2
intestinal dendritic cells suppressed inflammation and promoted tolerance by inducing T regulatory cells while suppressing the inflammatory T helper 1/T helper 17 responses (19) . Moreover, in a full-thickness skin wound model, deletion of b-cat in myeloid cells from Lysz-Cre mice inhibited macrophage migration and adhesion, ultimately preventing wound healing (20) . Together, these studies indicate that a careful understanding of the immune cell and context-specific activities of b-catenin signaling will be required to establish the contribution of this pathway in the pathogenesis of human diseases.
Work from our laboratory has demonstrated that global loss of the Wnt coreceptor, low density lipoprotein receptor-related protein 5 (Lrp5), attenuated bleomycin-induced pulmonary fibrosis (22) . To determine whether the major Wnt-responsive cell type contributing to fibrogenesis was from the lung parenchyma or hematopoietic in origin, we generated bone marrow chimeras using Lrp5 2/2 mice. We found that wildtype mice reconstituted with Lrp5 2/2 bone marrow cells were not protected from the development of fibrosis and, 3 weeks after bleomycin treatment, exhibited comparable levels of total lung collagen as chimeras reconstituted with Lrp5 1/1 bone marrow cells (22) . However, we noticed that chimeras with Lrp5 2/2 bone marrow cells showed a significant reduction in new collagen synthesis at 3 weeks (22) . This suggests that immune cells lacking Lrp5 may be sufficient to improve the resolution of fibrosis, perhaps by altering immune cell fates that favor tissue repair. Although our previous work has acknowledged the contributing role of Wnt/b-catenin signaling in lung parenchymal cell types to the injury and repair response (16, 17) , how b-catenin signaling modulates the immune response after lung injury is unknown. Here, we show that pathways related to the immune response and matrix processing are activated after bleomycin injury in Lrp5 
Microarray Analysis of Lung Tissue
Total RNA was extracted from tissue using RNeasy Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. Quality control and the probe level processing of the Illumina (Illumina Inc., San Diego, CA) microarray data were further made with R Bioconductor package "lumi". The data processing included a normalization procedure using the quantile normalization method to reduce the obscuring variation between microarrays, which might be introduced during the processes of sample preparation, manufacture, fluorescence labeling, hybridization, and/or scanning. Hierarchical clustering and principal component analysis were performed on the normalized signal data to assess variability of sampling. Probes absent in all samples were filtered out in the downstream analysis according to Illumina detection. Differential gene expression between the different conditions was assessed by a statistical linear model analysis using the Bioconductor package "limma," in which an empirical Bayes method is used to moderate the standard errors of the estimated log-fold changes of gene expression, and results in more stable inference and improved power, especially for experiments with small numbers of microarrays. Function analysis was performed on the differentially expressed gene lists using R Bioconductor package "topGO". Heat map for hierarchical clustering of the differentially expressed genes in Figure 1A was generated using Cluster 3.0 software (Michael Eisen; Stanford University, Stanford, CA). Functional gene set enrichment analysis was used to generate the functional gene network in Figure 1B 
Quantification of mRNA
Total RNA was extracted from tissue using RNeasy Kit (Qiagen, Valencia, CA)
S a l i n e B l e o m y c i n
Decreased in LRP5 Only genes up-regulated in bleomycin response relative to saline controls were included in the network. Colored nodes, functional gene term sets (functions indicated next to sets); white nodes, "hub" genes; triangles, genes upregulated in LRP5 2/2 lungs relative to WT controls during bleomycin response; "V" symbols, genes up-regulated in LRP5 2/2 lungs relative to WT controls during bleomycin response. (C) Real-time quantitative PCR (qPCR) validation in a second cohort of mice for gene expression of matrix metalloproteinase 13 (MMP13) and lysyl oxidase (LOX) (n = 5-9 animals per condition; *P , 0.05). Data presented are mean (6 SEM). BLEO, bleomycin; Ccr5, C-C motif chemokine receptor 5; Chodl, chondrolectin; EGF, epidermal growth factor; F13a1, family with sequence similarity 13 member A; Fbln2, fibulin 2; GAPDH, glyceraldehyde phosphate dehydrogenase; H2-Ob, histocompatibility 2, O region b locus; H2-Q8, histocompatibility 2, Q region locus 8; Lum, lumican; Lyz1, lysozyme 1; Mfap5, microfibrillar associated protein 5; Plat, plasminogen activator tissue type; Sirpb1a, signal-regulatory protein b 1A; Slpi, secretory leukocyte peptidase inhibitor; Trem2, triggering receptor expressed on myeloid cells 2; Wfdc12, WAP four-disulfide core domain protein 12. according to manufacturer's instructions. Real-time quantitative PCR primer sequences are as follows: mouse glyceraldehyde phosphate dehydrogenase (GAPDH) forward primer 59-TTGTGATG GGTGTGAACCACGAGA and reverse primer 59-GAGCCCTTCCACAATG CCAAAGTT; mouse AXIN2 forward 59-ACCTCAAGTGCAAACTCTCACCCA and reverse 59-AGCTGTTTCCGTGGATCTC ACACT; mouse MMP-13 forward 59-GATGGCACTGCTGACATCAT and reverse 59-CCCACCATAGTTTGGTCCAG; mouse lysyl oxidase (LOX) forward 59-TGCTATTCGATCCCACGCTGCTTA and reverse 59-TCCCTATGCCGTGAAA CCTCACAA. Real-time PCR (quantitative PCR) was performed using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA) with the MyiQ Single Color Real-Time PCR Detection System and software (Bio-Rad). GAPDH was used as the internal control. The relative change in gene expression was calculated using the 2 2ΔΔCt method. Lung leukocytes were isolated using GentleMACS dissociator (Miltenyi, Auburn, CA) as previously described (30) . Bone marrow-derived macrophages were generated from whole bone marrow cells isolated from the femurs and tibias of mice, followed by in vitro differentiation in Dulbecco's modified Eagle's medium supplemented with 10% FBS, 1% penicillin/streptomycin, and 20% L929 supernatant containing mouse granulocyte/macrophage colony-stimulating factorr. Flow cytometry and cell sorting were performed using LSR II flow cytometer (BD Biosciences, San Jose, CA) as previously described (30) (see Figure E4 and Tables  E1-E3 in the online supplement).
Immunohistochemistry and Imaging
b-galactosidase (b-gal) staining was performed as previously described (16 We previously demonstrated that mice lacking Lrp5 globally were protected from bleomycin-induced pulmonary fibrosis (22) Figure 1B and Figure E1 ). As Lox and Mmp13 have established roles in matrix processing (23) (24) (25) (26) , we sought to corroborate the robustness of the microarray findings ( Figure 1A ) and confirmed that Lox and Mmp13 expression were also highly increased in the replication cohort (3.9 6 1.0-fold versus 1.0 6 0.3-fold and 5.8 6 2.0-fold versus 1.1 6 0.2-fold, respectively; Figure 1C ).
b-Catenin Signaling Is Activated in Macrophages of Uninjured Lungs
To determine whether immune cells of the lung receive Wnt/b-catenin signals under baseline conditions, we used a reporter mouse in which the b-gal gene is knocked into the endogenous Axin2 gene (27) , an established downstream target of b-catenin and T cell factor transcription factor activity (27) (28) (29) . Analysis by flow cytometry using fluorescein di-b-Dgalactopyranoside, which is hydrolyzed by b-gal to fluorescein, demonstrated that b-catenin/T cell factor signaling activity can be detected in many myeloid cell subgroups of the lung, particularly AMs, interstitial macrophages (IMs), and monocytes ( Figure 2A Figures  2B and 2B' ). Although the majority of b-gal 1 cells appear morphologically to be of immune cell origin, there are also some nonimmune cell types in the distal lungs, such as epithelial cells or fibroblasts, which were previously shown to exhibit activation of b-catenin signaling (16, 22) .
Differentiation of AMs Is Reduced in lrp5
2/2 Mice after Bleomycin Injury and Contributes to Improved
Resolution of Fibrosis
As the Wnt/b-catenin pathway has been shown to determine cell fate, we speculated that b-catenin signaling might alter lung macrophage differentiation, such that loss of Lrp5 in lung macrophages may contribute to a milieu that promotes resolution of fibrosis. In the uninjured lung, tissue-resident AMs are believed to be long lived, populating the lung during early embryogenesis and self-renewing with minimal replenishment from bone marrow-derived cells (31, 32) . Intratracheally administered bleomycin induced apoptosis of tissue-resident (Siglec F high ) AMs (TR-AM), which were then reconstituted from recruited bone marrow-derived cells (33) (34) (35) (36) . During the acute phase (Day 5), the number of AMs significantly decreased, whereas the number of IMs increased; during the fibrotic phase (Day 21), AM numbers increased, whereas IM numbers returned to basal levels (30) . The increased AM population coincided with the emergence of a new population of Siglec and Lrp5 2/2 mice ( Figure E5 ). Together, these findings reveal that, during the fibrotic phase of bleomycin lung injury, b-catenin signaling promotes differentiation of recruited Mo-AM populations that contribute to the fibrotic phenotype.
As the Lrp5 2/2 mice have globally diminished Wnt/b-catenin signaling, CD11c cre ;b-catenin flox mice were used to investigate loss of b-catenin specifically in lung macrophages. We confirmed that myeloid cells are responsive to a canonical Wnt ligand in vitro using bone marrow-derived macrophages from wildtype mice ( Figure E2 ). The presence of recombinant Wnt3a increased gene expression of the immediate downstream target, Axin2 ( Figure E2A) , and stabilized the cytosolic, signaling pool of b-catenin ( Figure E2B ). Loss of b-catenin in CD11c cre bone marrowderived macrophages diminished the cytosolic pool of b-catenin basally and after stimulation with recombinant Wnt3a ( Figure E3 ).
When CD11c cre ;b-catenin flox mice were treated with intratracheal bleomycin, we found no differences in lung collagen content or bronchoalveolar lavage fluid total protein levels during the acute phase of bleomycin injury at Day 6 or during the fibrotic phase at Day 21 ( Figures 4A-4D) . However, there was improved resolution of bleomycin-induced pulmonary fibrosis at 8 weeks compared with CD11c (Figures 4E-4G) . Recent detailed analysis of the bleomycin model demonstrated that the fibrotic phase continued up to 8 weeks, after which time there was spontaneous resolution (37) . Thus, loss of b-catenin in CD11c 1 macrophages appeared to diminish the persistent fibrotic response to bleomycin and facilitate resolution of injury.
We confirmed that these findings are not limited to bleomycin by using a second model of fibrosis with asbestos. The intratracheal asbestos model has been reported to generate a progressive, nonresolving form of pulmonary fibrosis in which macrophage cell numbers were increased from Weeks 1 to 4 and fibrosis persisted at least through Week 24 (38) (39) (40) . We demonstrated that one dose of intratracheal asbestos in Lrp5 2/2 mice resulted in increased collagen deposition by 3 weeks that was similar to asbestostreated Lrp5 1/1 mice, but, consistent with our findings in the CD11c cre ;b-catenin flox mice, collagen deposition was markedly decreased by 8 weeks in Lrp5 2/2 mice (Figures 5A-5C ). Similar to our findings in the bleomycin model with the Lrp5 mice, we found that, by 8 weeks, there were no differences in the populations of IMs, TR-AMs, or recruited Mo-AMs between Lrp5 1/1 and Lrp5 2/2 mice ( Figure E6 ).
To support that these results are due specifically to decreased Wnt/b-catenin signaling, we used the chemical, LiCl, which inhibits glycogen synthase kinase 3 b phosphorylation and has been previously reported to activate b-catenin in the lung (16) . We found that daily intraperitoneal LiCl administration in wild-type mice increased collagen deposition and injury at 3 weeks, regardless of whether it was given immediately after bleomycin injury or in a delayed fashion (Figures 5D and 5E ), suggesting that, at these early time points, b-catenin signaling has profibrotic effects on multiple cell types. In contrast to the findings associated with inhibition of b-catenin signaling in Lrp5 2/2 or CD11c cre ;b-catenin flox mice, activation of b-catenin signaling by LiCl during Weeks 2 and 3 after bleomycin injury in wild-type mice led to prolonged deposition of collagen, such that there was more collagen after 8 weeks than in the lungs of sodium chloride control bleomycin-treated mice ( Figure 5F ). Overall, these findings provide evidence that Wnt/b-catenin signaling alters differentiation of AMs and contributes to persistence of fibrosis after lung injury.
Discussion
We previously found that mice with global loss of the Wnt coreceptor, Lrp5, were protected from bleomycin-induced pulmonary fibrosis; in these mice, gene pathways related to matrix processing and innate immunity are altered. The finding that Wnt/b-catenin signaling affects matrix processing is consistent with reports that link b-catenin signaling with the transforming growth factor-b pathway, fibroblast proliferation, and collagen synthesis (41) (42) (43) (44) (45) . Among the top upregulated genes was lysyl oxidase, a collagen cross-linking enzyme that has been linked to disrupted matrix synthesis in a transforming growth factor-b-dependent manner (23, (46) (47) (48) , although inhibition of another family member, LOXL2, protects from fibrosis (49) and is currently in phase 2 clinical trials for the treatment of idiopathic pulmonary fibrosis (50). Mmp-13, a macrophage-associated metalloproteinase, also known as collagenase-3, is also highly increased in Lrp5-null lungs after bleomycin injury, and has been shown to limit the development of fibrosis (25, 26) . Our finding, that loss of a Wnt coreceptor is associated with changes in genes that regulate the innate immune response, is unexpected, given the paucity of data linking these two pathways in the lung. Heise and colleagues (51) previously proposed that stretch-induced epithelial mesenchymal transition is mediated by myeloid differentiation primary response 88 in a Wnt/b-catenin-dependent manner, and, in an influenza A model, b-catenin has also been reported to inhibit viral replication in alveolar epithelial cells via an IFN-g-dependent mechanism (52). However, abundant literature exists supporting the importance of Wnt/bcatenin signaling in determining cell fate during embryogenesis (6, 7) , as well as adult homeostasis (9, 10) . Thus, Wnt/b-cat signaling may play an important role in the differentiation of innate immune cells after lung injury.
As macrophages have been shown to contribute to the development of pulmonary fibrosis (53-56), we investigated whether cells of monocyte-macrophage lineage show Wnt/b-catenin signaling activation. Indeed, myeloid cells of the lung, including AMs, IMs, monocytes, CD11b 1 dendritic cells, and neutrophils displayed evidence of active b-catenin signaling using an Axin2 reporter mouse. Furthermore, bone marrow-derived macrophages were able to respond to the canonical ligand, Wnt3a, by increasing stabilization of the cytosolic, signaling pool of b-catenin and by increasing gene expression of the immediate down-stream target Axin2. This is consistent with previous reports in the literature where manipulation of b-catenin signaling in intestinal dendritic cells and T regulatory lymphocytes altered the innate immune response (18, 19) .
In determining whether Wnt/b-cat signaling plays an important role in the differentiation of myeloid cells after lung injury, flow cytometry analysis at Day 21 after bleomycin administration, when there was previously observed decreased fibrosis in the Lrp5 2/2 lungs (22), revealed that there were fewer numbers of recruited Mo-AMs. These Mo-AMs, which emerge during the fibrotic phase, represent monocyte-derived IMs that differentiated into AMs to replace the TR-AMs that ;b-catenin flox mice and CD11c 2/2 ;b-catenin flox mice were treated with bleomycin or saline, and lungs were harvested for total collagen content by hydroxyproline assay and total protein content of bronchoalveolar (BAL) fluid after (A and B) 6 days and (C and D) 21 days (n = 5 animals per condition; *P , 0.05, **P , 0.01, ***P , 0.001). After 8 weeks, (E) total lung collagen content was measured by hydroxyproline assay, and (F) gene expression of collagen 1A1 (COL1A1) was determined by real-time qPCR (**P , 0.01, ***P , 0.001). Data presented are mean (6 SEM). (G) Histology of bleomycin-treated lungs stained with hematoxylin and eosin (H&E; n = 4-5 mice per condition). Insets indicate areas that are magnified in the images to the right. underwent apoptosis after bleomycin injury (30) .
As macrophages may promote the resolution of fibrosis by a number of mechanisms (2), we speculated that loss of Wnt/b-catenin signaling mediated changes in macrophage differentiation that may contribute to an overall proresolution environment. Our finding that loss of b-catenin in CD11c 1 macrophages improved resolution of bleomycin-induced pulmonary fibrosis confirms an important role of Wnt/b-catenin signaling in monocyte-macrophage differentiation to promote aberrant wound healing. We acknowledge that CD11c is also expressed in lung dendritic cells, and thus, a contribution from the dendritic cell compartment to the phenotype cannot be completely excluded in this model. The potential role of b-catenin in the differentiation of dendritic cells has been investigated recently in a mouse model of inflammatory bowel disease (19) .
However, the role of dendritic cells in lung wound healing and fibrosis remains poorly studied, and, specifically, the role of b-catenin in the differentiation of dendritic cells in the lung is unknown and an area of active interest in our laboratory.
Nonetheless, similar findings of improved resolution in a second model of pulmonary fibrosis using asbestos in maintaining the persistence of pulmonary fibrosis was demonstrated by the fact that administration of the Wnt/b-catenin activator, LiCl, from Days 7-21, when recruited Mo-AMs were reported to be highest, resulted in the deposition of more collagen by the end of the fibrotic phase at Day 56.
Overall, Wnt/b-catenin signaling has effects in multiple cell types of the lung that contribute to the development and persistence of pulmonary fibrosis. We have shown that macrophages with activated b-catenin signaling play a role in sustaining pulmonary fibrosis after bleomycin and asbestos injury. Wnt signaling in the developing lung occurs in both autocrine and paracrine manners in the epithelium and mesenchyme (6), whereby alveolar epithelial cells, fibroblasts, and macrophages may all be the producers, as well as recipients, of a Wnt signal. Therefore, the potential effects of Wnt/b-catenin signaling in macrophages may be both cell autonomous and cell nonautonomous, reflecting likely complex macrophage-epithelial and macrophage-mesenchymal interactions that require further investigation. n Author disclosures are available with the text of this article at www.atsjournals.org.
